本页面由Tiger Trade Technology Pte. Ltd.提供服务

Kiniksa Pharmaceuticals Ltd.

79.24
-0.5400-0.68%
盘前:79.640.3964+0.50%04:00 EDT
成交量:34.09万
成交额:2,716.71万
市值:61.83亿
市盈率:80.04
高:80.99
开:80.00
低:78.82
收:79.78
52周最高:82.94
52周最低:35.20
股本:7,802.40万
流通股本:3,994.15万
量比:0.86
换手率:0.85%
股息:- -
股息率:- -
每股收益(TTM):0.9900
每股收益(LYR):0.7500
净资产收益率:14.04%
总资产收益率:8.05%
市净率:9.45
市盈率(LYR):105.65

数据加载中...

2025/04/29

重要事件披露

Form 8-K - Current report
2025/04/23

重要事件披露

Form 8-K - Current report
2025/04/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/26

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/25

重要事件披露

Form 8-K - Current report
2025/02/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2024/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]